AMP Capital Investors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-611,177
| Closed | -$69.2M | – | 459 |
|
|
2021
Q3 | $69.2M | Sell |
611,177
-85,564
| -12% | -$9.77M | 0.38% | 56 |
|
|
2021
Q2 | $72.2M | Buy |
696,741
+28,825
| +4% | +$2.72M | 0.35% | 63 |
|
|
2021
Q1 | $55.8M | Buy |
667,916
+139,269
| +26% | +$11.8M | 0.28% | 83 |
|
|
2020
Q4 | $47.4M | Sell |
528,647
-41,622
| -7% | -$3.45M | 0.26% | 94 |
|
|
2020
Q3 | $44.7M | Sell |
570,269
-84,097
| -13% | -$6.56M | 0.26% | 92 |
|
|
2020
Q2 | $44.4M | Buy |
654,366
+122,067
| +23% | +$8.67M | 0.28% | 88 |
|
|
2020
Q1 | $34.8M | Buy |
532,299
+16,971
| +3% | +$1.22M | 0.26% | 93 |
|
|
2019
Q4 | $39.9M | Buy |
515,328
+130,290
| +34% | +$10.2M | 0.22% | 113 |
|
|
2019
Q3 | $27.9M | Sell |
385,038
-24,306
| -6% | -$1.71M | 0.16% | 166 |
|
|
2019
Q2 | $25.3M | Buy |
409,344
+17,598
| +4% | +$1.06M | 0.14% | 181 |
|
|
2019
Q1 | $24.7M | Buy |
391,746
+73,212
| +23% | +$4.18M | 0.14% | 175 |
|
|
2018
Q4 | $16M | Buy |
318,534
+43,896
| +16% | +$2.22M | 0.1% | 229 |
|
|
2018
Q3 | $15.8M | Buy |
274,638
+50,103
| +22% | +$2.45M | 0.09% | 270 |
|
|
2018
Q2 | $10.9M | Sell |
224,535
-31,365
| -12% | -$1.46M | 0.06% | 355 |
|
|
2018
Q1 | $11.7M | Buy |
255,900
+29,883
| +13% | +$1.3M | 0.07% | 336 |
|
|
2017
Q4 | $8.49M | Sell |
226,017
-1,584
| -0.7% | -$58.1K | 0.05% | 415 |
|
|
2017
Q3 | $8.29M | Sell |
227,601
-48,198
| -17% | -$1.84M | 0.05% | 403 |
|
|
2017
Q2 | $10.8M | Sell |
275,799
-9,177
| -3% | -$335K | 0.06% | 324 |
|
|
2017
Q1 | $8.91M | Sell |
284,976
-72,891
| -20% | -$2.28M | 0.05% | 381 |
|
|
2016
Q4 | $11.2M | Sell |
357,867
-191,262
| -35% | -$6.2M | 0.07% | 320 |
|
|
2016
Q3 | $21.8M | Buy |
549,129
+44,184
| +9% | +$1.66M | 0.13% | 173 |
|
|
2016
Q2 | $16.3M | Buy |
504,945
+85,800
| +20% | +$2.94M | 0.11% | 208 |
|
|
2016
Q1 | $12.4M | Buy |
419,145
+46,491
| +12% | +$1.28M | 0.08% | 254 |
|
|
2015
Q4 | $9.84M | Sell |
372,654
-136,572
| -27% | -$3.55M | 0.07% | 318 |
|
|
2015
Q3 | $11.7M | Sell |
509,226
-405,276
| -44% | -$9.78M | 0.09% | 248 |
|
|
2015
Q2 | $21.7M | Sell |
914,502
-103,758
| -10% | -$2.34M | 0.14% | 180 |
|
|
2015
Q1 | $24.5M | Buy |
1,018,260
+95,064
| +10% | +$2.13M | 0.15% | 170 |
|
|
2014
Q4 | $19.9M | Buy |
923,196
+196,320
| +27% | +$3.94M | 0.12% | 209 |
|
|
2014
Q3 | $12.5M | Buy |
726,876
+555,528
| +324% | +$8.77M | 0.08% | 287 |
|
|
2014
Q2 | $2.51M | Buy |
171,348
+7,200
| +4% | +$97.6K | 0.02% | 694 |
|
|
2014
Q1 | $1.95M | Sell |
164,148
-9,114
| -5% | -$105K | 0.01% | 726 |
|
|
2013
Q4 | $1.9M | Buy |
173,262
+42,600
| +33% | +$480K | 0.01% | 733 |
|
|
2013
Q3 | $1.5M | Sell |
130,662
-28,380
| -18% | -$332K | 0.01% | 759 |
|
|
2013
Q2 | $1.77M | Buy |
+159,042
| New | +$1.88M | 0.01% | 735 |
|
Other funds holding EW
AMP Capital Investors's EW Position: Q4 2021 in Review
AMP Capital Investors sold out of Edwards Lifesciences (EW) in Q4 2021, closing a stake of 611,177 shares — an estimated $69.2M sold.
AMP Capital Investors first reported a position in EW in Q2 2013 and held it in 34 quarters. The position peaked at $72.2M in Q2 2021. 1,321 funds tracked by Wall St. Rank hold EW as of Q4 2021.
- AMP Capital Investors reported no remaining Edwards Lifesciences position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 611,177 Edwards Lifesciences shares in Q4 2021, an estimated $69.2M.
- AMP Capital Investors first reported a position in Edwards Lifesciences in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's Edwards Lifesciences position peaked at $72.2M in Q2 2021.
- 1,321 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.